Authors:
Louvet, C
Andre, T
Hammel, P
Selle, F
Landi, B
Cattan, S
Fonck, M
Flesch, M
Colin, P
Balosso, J
Ruszniewski, P
de Gramont, A
Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679
Authors:
Andre, T
Balosso, J
Louvet, C
Hannoun, L
Houry, S
Huguier, M
Colonna, M
Lotz, JP
De Gramont, A
Bellaiche, A
Parc, R
Touboul, E
Izrael, V
Citation: T. Andre et al., Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study, INT J RAD O, 46(4), 2000, pp. 903-911
Citation: T. Andre et J. Balosso, Chemotherapy, combined radiochemotherapy and new therapeutic approaches for adenocarcinoma of the pancreas, J CHIR, 136(6), 1999, pp. 309-317
Authors:
Bolla, M
Artignan, X
Chirpaz, E
Balosso, J
Descotes, JL
Citation: M. Bolla et al., Current data on combined radiotherapy plus hormone therapy in localized and locally advanced cancer of the prostate, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 260-265